Molecular targeting therapy against EGFR family in breast cancer: progress and future potentials
AE Maennling, MK Tur, M Niebert, T Klockenbring… - Cancers, 2019 - mdpi.com
The epidermal growth factor receptor (EGFR) family contains four transmembrane tyrosine
kinases (EGFR1/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) and 13 secreted …
kinases (EGFR1/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) and 13 secreted …
Emerging role of exosomes as biomarkers in cancer treatment and diagnosis
NA Hanjani, N Esmaelizad, S Zanganeh… - Critical reviews in …, 2022 - Elsevier
Cancer is a leading cause of death worldwide and cancer incidence and mortality are
rapidly growing. These massive amounts of cancer patients require rapid diagnosis and …
rapidly growing. These massive amounts of cancer patients require rapid diagnosis and …
Are integrins still practicable targets for anti-cancer therapy?
B Alday-Parejo, R Stupp, C Rüegg - Cancers, 2019 - mdpi.com
Correlative clinical evidence and experimental observations indicate that integrin adhesion
receptors, in particular those of the αV family, are relevant to cancer cell features, including …
receptors, in particular those of the αV family, are relevant to cancer cell features, including …
Chronic niche inflammation in endometriosis-associated infertility: current understanding and future therapeutic strategies
YH Lin, YH Chen, HY Chang, HK Au, CR Tzeng… - International journal of …, 2018 - mdpi.com
Endometriosis is an estrogen-dependent inflammatory disease that affects up to 10% of
women of reproductive age and accounts for up to 50% of female infertility cases. It has …
women of reproductive age and accounts for up to 50% of female infertility cases. It has …
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
P Merikhian, MR Eisavand, L Farahmand - Cancer cell international, 2021 - Springer
Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-
positive breast cancers and all receptor tests come back negative. More importantly, the …
positive breast cancers and all receptor tests come back negative. More importantly, the …
Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1PR agonists
T Pérez-Jeldres, CJ Tyler, JD Boyer… - Frontiers in …, 2019 - frontiersin.org
The inflammatory Bowel diseases (IBDs) are a chronic, relapsing inflammatory diseases of
the gastrointestinal tract with heterogeneous behavior and prognosis. The introduction of …
the gastrointestinal tract with heterogeneous behavior and prognosis. The introduction of …
Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications
Y Xu, Q Hu, Z Wei, Y Ou, Y Cao, H Zhou… - Biomaterials …, 2023 - spj.science.org
Diabetic ulcers (DUs) are one of the most serious complications of diabetes mellitus. The
application of a functional dressing is a crucial step in DU treatment and is associated with …
application of a functional dressing is a crucial step in DU treatment and is associated with …
Treatment of metastatic melanoma with a combination of immunotherapies and molecularly targeted therapies
T Rager, A Eckburg, M Patel, R Qiu, S Gantiwala… - Cancers, 2022 - mdpi.com
Simple Summary Immunotherapies and molecularly targeted therapies have drastically
changed the therapeutic approach for unresectable advanced or metastatic melanoma. The …
changed the therapeutic approach for unresectable advanced or metastatic melanoma. The …
[图书][B] Molecular biology of human cancers
WA Schulz - 2023 - Springer
viii everybody who contributed to the first edition. As always, I have to thank my wife and
family for encouragement and support (as well as patience…). I hope you will find this book …
family for encouragement and support (as well as patience…). I hope you will find this book …
[HTML][HTML] Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway
H Li, X Sun, J Li, W Liu, G Pan, A Mao, J Liu, Q Zhang… - Neoplasia, 2022 - Elsevier
Cytotoxic chemotherapy is the major strategy to prevent and reduce triple-negative breast
cancer (TNBC) progression and metastasis. Hypoxia increases chemoresistance and is …
cancer (TNBC) progression and metastasis. Hypoxia increases chemoresistance and is …